What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.75%
Annual Rate
SAR 0.15Paid annual
Payout Ratio
375.0%High
Payback Period
57.1 yr
Last Ex-Dividend
Jun 15, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.38BSAR
367.76M · vs all stocks (USD)
Updated Nov 21, 2026
Trailing P/E
285.67x
vs Conglomerates peers
Updated Nov 21, 2026
Revenue (TTM)
497.22MSAR
132.59M · vs all stocks (USD)
Updated Nov 21, 2026
Profit Margin
1.46%
vs Conglomerates peers
Updated Nov 21, 2026
Beta
0.2340x
vs all stocks
Updated Nov 21, 2026
52-Week Change
-58.40%
vs all stocks
Updated Nov 21, 2026
Market Capitalization
1.38BSAR
367.76M · vs all stocks (USD)
Updated Nov 21, 2026
Enterprise Value
2.10BSAR
560.32M · vs all stocks (USD)
Updated Nov 21, 2026
Trailing P/E
285.67x
vs Conglomerates peers
Updated Nov 21, 2026
Forward P/E
21.42x
vs Conglomerates peers
Updated Nov 21, 2026
PEG Ratio
-4.76x
vs Conglomerates peers
Updated Nov 21, 2026
Price to Sales (TTM)
2.77x
vs Conglomerates peers
Updated Nov 21, 2026
Price to Book (MRQ)
2.68x
vs Conglomerates peers
Updated Nov 21, 2026
Enterprise to Revenue
4.23x
vs Conglomerates peers
Updated Nov 21, 2026
Enterprise to EBITDA
38.05x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 18.02×.Updated Nov 21, 2026
Gross Margin
10.99%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 15.53%.Updated Nov 21, 2026
Profit Margin
1.46%
vs Conglomerates peers
Updated Nov 21, 2026
Operating Margin
3.70%
vs Conglomerates peers
Updated Nov 21, 2026
Return on Assets (TTM)
0.69%
vs Conglomerates peers
Updated Nov 21, 2026
Return on Equity (TTM)
1.98%
vs Conglomerates peers
Updated Nov 21, 2026
Revenue (TTM)
497.22MSAR
132.59M · vs all stocks (USD)
Updated Nov 21, 2026
Revenue per Share (TTM)
3.09SARUpdated Nov 21, 2026
Quarterly Revenue Growth
-42.50%
vs Conglomerates peers
Updated Nov 21, 2026
Gross Profit (TTM)
77.24MSAR
20.60M · vs all stocks (USD)
Updated Nov 21, 2026
EBITDA (TTM)
116.58MSAR
31.09M · vs all stocks (USD)
Updated Nov 21, 2026
Net Income (TTM)
7.25MSAR
1.93M · vs all stocks (USD)
Updated Nov 21, 2026
Quarterly Earnings Growth (YoY)
-40.70%
vs Conglomerates peers
Updated Nov 21, 2026
Operating Cash Flow (TTM)
66.16MSAR
17.64M · vs all stocks (USD)
Updated Nov 21, 2026
Levered Free Cash Flow (TTM)
-123.55MSAR
-32.95M · vs all stocks (USD)
Updated Nov 21, 2026
Trailing Annual Dividend Rate
0.1500SARUpdated Nov 21, 2026
Trailing Annual Dividend Yield
1.75%
vs all stocks
Updated Nov 21, 2026
Payout Ratio
375.00%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 500%.Updated Nov 21, 2026
Minority Interest (Equity)
4.32MSARFY2025 · Dec 31, 2025
Revenue
699.65MSARFY2025 · Dec 31, 2025
Cost of Goods Sold
586.00MSARFY2025 · Dec 31, 2025
Gross Profit
113.66MSARFY2025 · Dec 31, 2025
Operating Income
83.95MSAR
22.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
82.38MSARFY2025 · Dec 31, 2025
Income Tax Expense
6.62MSARFY2025 · Dec 31, 2025
Net Income
75.76MSARFY2025 · Dec 31, 2025
EBIT
131.48MSARFY2025 · Dec 31, 2025
EBITDA (Income Statement)
177.67MSARFY2025 · Dec 31, 2025
Selling, General & Administrative
19.50MSARFY2025 · Dec 31, 2025
Other Operating Expenses
564.79KSARFY2025 · Dec 31, 2025
Non-operating Interest Income
43.15MSARFY2025 · Dec 31, 2025
Non-operating Interest Expense
49.10MSARFY2025 · Dec 31, 2025
EPS (Basic)
0.4500SARFY2025 · Dec 31, 2025
EPS (Diluted)
0.4500SARFY2025 · Dec 31, 2025
Basic Shares Outstanding
160.93MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
160.93MSharesFY2025 · Dec 31, 2025
Minority Interests (P&L)
-3.35MSARFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00SARFY2025 · Dec 31, 2025
Operating Cash Flow
134.91MSARFY2025 · Dec 31, 2025
Free Cash Flow
129.42MSARFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
305.71MSARFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
82.38MSARFY2025 · Dec 31, 2025
Stock-based Compensation
824.09KSARFY2025 · Dec 31, 2025
Other Non-cash Items
40.60MSARFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
10.14MSARFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
959.55KSARFY2025 · Dec 31, 2025
Capital Expenditures
-5.49MSARFY2025 · Dec 31, 2025
Net Intangibles (CF)
-30.08MSARFY2025 · Dec 31, 2025
Net Acquisitions
0.00SARFY2025 · Dec 31, 2025
Purchase of Investments
-154.50MSARFY2025 · Dec 31, 2025
Sale of Investments
179.50MSARFY2025 · Dec 31, 2025
Other Investing Activity
-227.85MSARFY2025 · Dec 31, 2025
Net Investing Cash Flow
-208.34MSARFY2025 · Dec 31, 2025
Long-term Debt Issuance
470.99MSARFY2025 · Dec 31, 2025
Long-term Debt Payments
-194.83MSARFY2025 · Dec 31, 2025
Common Dividends Paid
-16.09MSARFY2025 · Dec 31, 2025
Other Financing Charges
45.00KSARFY2025 · Dec 31, 2025
Net Financing Cash Flow
260.11MSARFY2025 · Dec 31, 2025
Shares Outstanding
160.93MSharesUpdated Nov 21, 2026
Float Shares
64.37MSharesUpdated Nov 21, 2026
% Held by Insiders
0.00%
vs all stocks
Updated Nov 21, 2026
% Held by Institutions
60.08%
vs all stocks
Updated Nov 21, 2026
Total Cash (MRQ)
204.25MSAR
54.47M · vs all stocks (USD)
Updated Nov 21, 2026
Total Cash per Share (MRQ)
1.27SARUpdated Nov 21, 2026
Total Debt (MRQ)
912.09MSAR
243.22M · vs all stocks (USD)
Updated Nov 21, 2026
Total Debt to Equity (MRQ)
1.73x
vs Conglomerates peers
Updated Nov 21, 2026
Current Ratio (MRQ)
1.33x
vs Conglomerates peers
Updated Nov 21, 2026
Book Value per Share (MRQ)
3.20SARUpdated Nov 21, 2026
Total Assets
1.68BSAR
449.23M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
520.91MSARFY2025 · Dec 31, 2025
Total Liabilities
1.21BSARFY2025 · Dec 31, 2025
Total Non-current Assets
1.16BSARFY2025 · Dec 31, 2025
Total Non-current Liabilities
872.55MSARFY2025 · Dec 31, 2025
Total Current Liabilities
333.08MSARFY2025 · Dec 31, 2025
Cash
138.03MSARFY2025 · Dec 31, 2025
Cash Equivalents
167.68MSARFY2025 · Dec 31, 2025
Cash & Cash Equivalents
305.71MSARFY2025 · Dec 31, 2025
Other Short-term Investments
55.00MSARFY2025 · Dec 31, 2025
Accounts Receivable
47.68MSARFY2025 · Dec 31, 2025
Inventory
6.42MSARFY2025 · Dec 31, 2025
Accounts Payable
133.28MSARFY2025 · Dec 31, 2025
Short-term Debt
47.97MSARFY2025 · Dec 31, 2025
Long-term Debt
784.36MSARFY2025 · Dec 31, 2025
Common Stock (Book)
160.93MSARFY2025 · Dec 31, 2025
Retained Earnings
332.36MSARFY2025 · Dec 31, 2025
Total Shareholders' Equity
479.02MSAR
127.73M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
7.59SARUpdated Nov 21, 2026
52-Week High
21.89SARUpdated Nov 21, 2026
52-Week Change
-58.40%
vs all stocks
Updated Nov 21, 2026
Beta
0.2340x
vs all stocks
Updated Nov 21, 2026
50-Day MA
9.50SARUpdated Nov 21, 2026
200-Day MA
13.40SARUpdated Nov 21, 2026
Avg 10-Day Volume
1.18MSharesUpdated Nov 21, 2026
Avg 30-Day Volume
1.52MSharesUpdated Nov 21, 2026
Diluted EPS (TTM)
0.0300SARUpdated Nov 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 285.67×, higher than 95% of its Conglomerates peers (median 17.87×)Significant